Liver Cancer Trial, Recruiting NCT01050296 Sponsor: St. Jude Children's Research Hospital Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT01050296
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a suspected or known diagnosis of neuroblastoma, osteosarcoma, Ewing sarcoma, or soft tissue sarcoma, with a tumour that can be surgically removed — tissue, bone marrow, or blood samples may be collected at different points such as biopsy, surgery, or if the cancer returns.
  • People diagnosed with retinoblastoma (a type of eye cancer) who need to have an eye removed, but only if no other active research or treatment study for retinoblastoma is currently available to them (confirm with trial site).
  • People who are 25 years old or younger at the time of joining the trial.
  • People who are being seen at St. Jude Children's Research Hospital or at a partnering hospital.
  • People (or their legal guardian, if applicable) who are able to provide written consent within 30 days of the first tissue, bone marrow, or blood sample being collected.

Who may not be able to join:

  • People who are known to be positive for Hepatitis B, Hepatitis C, or HIV.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sara M. Federico, MD, St. Jude Children's Research Hospital

Phone: 1-866-278-5833

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
St. Jude Children's Research Hospital
Registry
ClinicalTrials.gov
Start date
10 February 2010
Est. completion
30 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Perform analysis of gene expression profiles. [RNA] ribonucleic acid will be isolated from fresh frozen tumor specimens and hybridized to Affymetrix gene expression arrays.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov